![Christopher Zergebel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Zergebel
Directeur Technique/Scientifique/R&D chez
LB PHARMACEUTICALS INC
Profil
Christopher Zergebel is Senior Vice President-Clinical Operations at LB Pharmaceuticals, Inc. since 2026.
Formerly, Mr. Zergebel was Vice President-Development & Operations at Cellectis Biologics, Inc. Mr. Zergebel completed undergraduate studies at Boston University.
Postes actifs de Christopher Zergebel
| Sociétés | Poste | Début |
|---|---|---|
| LB PHARMACEUTICALS INC | Directeur Technique/Scientifique/R&D | 30/06/2026 |
Anciens postes connus de Christopher Zergebel
| Sociétés | Poste | Fin |
|---|---|---|
Cellectis Biologics, Inc.
 Cellectis Biologics, Inc. Medical DistributorsDistribution Services Part of Cellectis SA, Cellectis Biologics, Inc. is a clinical-stage biopharmaceutical company that specializes in developing allogeneic cancer therapies using proprietary gene-editing technologies. The company is based in NC. Cellectis harnesses the immune system to target and eradicate cancer cells, utilizing their flagship technology and PulseAgile electroporation system. The company aims to develop a new generation of immunotherapy product candidates with enhanced safety and efficacy attributes, capable of overcoming mechanisms that inhibit immune system activity. Cellectis is dedicated to addressing the medical and food needs of a growing population and upholding good corporate governance. André Choulika has been the CEO of the company since 2019. | Directeur des opérations | - |
Formation de Christopher Zergebel
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
17
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LB Pharmaceuticals, Inc.
 LB Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression and neuropsychiatric diseases | Health Technology |
Cellectis Biologics, Inc.
Cellectis Biologics, Inc. Medical DistributorsDistribution Services Part of Cellectis SA, Cellectis Biologics, Inc. is a clinical-stage biopharmaceutical company that specializes in developing allogeneic cancer therapies using proprietary gene-editing technologies. The company is based in NC. Cellectis harnesses the immune system to target and eradicate cancer cells, utilizing their flagship technology and PulseAgile electroporation system. The company aims to develop a new generation of immunotherapy product candidates with enhanced safety and efficacy attributes, capable of overcoming mechanisms that inhibit immune system activity. Cellectis is dedicated to addressing the medical and food needs of a growing population and upholding good corporate governance. André Choulika has been the CEO of the company since 2019. | Distribution Services |
